1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
Global Radiation Therapy in the Oncology Market: Focus on Radiation Therapy Systems, Product Regulation, Key Strategies and Developments, Market Dynamics, 15 Company Profiles, and 12 Countries Data and Cross Segmentation - Analysis and Forecast, 2021-2031

Global Radiation Therapy in the Oncology Market: Focus on Radiation Therapy Systems, Product Regulation, Key Strategies and Developments, Market Dynamics, 15 Company Profiles, and 12 Countries Data and Cross Segmentation - Analysis and Forecast, 2021-2031

  • July 2021
  • 203 pages
  • ID: 6107147
  • Format: PDF
  • BIS Research

Summary

Table of Contents

Global Radiation Therapy in the Oncology Market to Reach $9,206.6 Million by 2031

Market Report Coverage - Radiation Therapy in the Oncology

Market Segmentation

• Radiation – External Beam Radiation, Internal Beam Radiation
• Product – Oncology Systems, Particle Therapy Systems (Proton and Heavy-Ion), Others
• Therapy – Stereotactic Radiosurgery (SRS), Brachytherapy, Image-Guided Radiation Therapy (IGRT), Intensity-Modulated Radiation Therapy (IMRT), Volumetric-Modulated Arc Therapy (VMAT)
• End User – Hospitals & Medical Research Institutes, Specialized Radiotherapy Centers (SRCs)
• Region – North America, Europe, Asia-Pacific, Rest-of-the-World

Regional Segmentation

• North America – U.S., Canada
• Europe – Germany, France, Spain, U.K., Italy, Rest-of-Europe
• Asia-Pacific – Japan, South Korea, India, China, Australia and New Zealand, Rest-of-Asia-Pacific
• Rest-of-the-World

Market Growth Drivers

• Rising Incidence and Prevalence of Neoplastic Patients and Elevating Geriatric Population
• Rising Demand for Reduced Radiation Exposure During Radiotherapy
• Technological Advancements in the Field of Radiotherapy

Market Challenges

• High Cost of Radiotherapy Systems and their Associated Procedures
• Highly Regulated Market due to the Use of Radiation

Market Opportunities

• Development of Low-Cost Cancer Treatment Center
• Implementation of Machine Learning in Radiotherapy Systems

Key Companies Profiled

Accuray Inc., Eckert & Ziegler AG, Elekta AB, General Electric Company, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Mevion Medical Systems Inc., TeamBest Group, Reflexion Medical Inc., Sensus Healthcare Inc., Varian Medical Systems Inc. (Siemens Healthineers AG), Xoft Inc. (iCAD Inc.), Xstrahl Inc., Zap Surgical Systems Ltd.

Who should buy this report?

• Radiation Therapy Systems Parts OEMs
• Accelerator Manufacturers
• Radiation Therapy Systems Manufacturers
• Software Developers
• Imaging Modalities (MRI, CT, PET, Ultrasound, among others) Manufactures

Key questions answered in the Report

• Which are the consortiums in the radiation therapy market, and what is their role in the market?
• How is the funding scenario in the radiation therapy market?
• What are the major market drivers, challenges, and opportunities in the global radiation therapy in oncology market?
• What is the market trend within the radiation therapy systems industry?
• What was the market value of the leading segments of the global radiation therapy in oncology market in 2020?
• How will the industry evolve during the forecast period 2021-2031?
• What are the key developmental strategies implemented by the key players to sustain in the competitive market?
• What is the current market share of each of the companies in the global radiation therapy in oncology market and what will be their contribution in 2031?
• What is the growth potential of radiation therapy in oncology market in each region, including North America, Europe, Asia-Pacific, and Rest-of-the-World?
• What are the key regulatory implications in developed and developing regions for radiation therapy systems and associated procedures?

Radiation Therapy in Oncology Market Overview

Radiation therapy in the oncology market is a treatment method to treat any type of cancer/ tumor with the help of radiation.Radiation therapy uses radiation beams made of photon, proton, heavy-ion, and other particles.

These radiation beams of intense energy are used to destroy or shrink the cancer/ tumor cells.

The term ‘radiation therapy’ mostly refers to the external beam radiation therapy, but it also means internal beam radiation therapy too.The external beam radiation therapy is done with the help of a machine outside the patient’s body that produces high-energy radiation beam and then aims the beam to a localized precise point or area of treatment on the patient’s body.

Whereas the internal beam radiation therapy is a method to place radiation (radioactive source) inside the patient’s body.

The radiation therapy systems (machines) available in the market are, namely, linear accelerator (LINAC), cyclotrons, synchrotrons, synchrocyclotrons, and conventional and electronic brachytherapy systems.

The radiation therapy in oncology report highlights that the market was valued at $5,481.8 million in 2020 and is expected to reach $9,206.6 million by the end of 2031. The market is expected to grow at a CAGR of 5.0% during the forecast period from 2021 to 2031.

Radiation Therapy Market Drivers

Presently, the factors driving the growth of the market as per the radiation therapy report include rising incidence and prevalence of neoplastic patients, elevating geriatric population, rising demand for reduced radiation exposure during radiotherapy, technological advancements in the field of radiotherapy.

All the radiation therapy systems, such as external beam radiation systems or internal beam radiation systems are based on using radiation beam to treat cancer/tumor.The radiation beam destroys the cell’s DNA thus, resulting in the shrinkage or destruction of the cancer/ tumor.

This cancer/ tumor treatment by radiation beam has resolved treatment of complex cancer/ tumor and providing less side effects when compared to traditional radiation therapy by x-ray or cobalt-60, or chemotherapy.

Radiation Therapy Market Challenges

The challenges that are restricting the growth of the market include high cost of radiotherapy systems and their associated procedures, and highly regulated market due to the use of radioactivity.

High cost of the system and their associated procedures are among the most challenging factors for the end-user to buy and treatment delivery for patients.It has been observed that many patients prefer international travel for their treatment to take the advantage of currency rate.

Also, due to the highly regulated market because of the use of the radioactivity have led the company to strictly obey the regulations to commercialize their products. Lack of accuracy in beam or radiation dose delivery is another factor affecting the growth of the global radiation therapy in oncology market.

Radiation Therapy Market Opportunities

Potential opportunities that is likely to boost the growth of the market include development of low-cost cancer treatment centers, developing radiation therapy system which is cost effective, and implementation of machine learning in radiation therapy system.

The current radiation therapy systems have a price of more than $2 million, therefore many companies are working in developing cost-effective system and even working towards the development of a low-cost infrastructure facility for the radiation therapy. And with time, technologically advanced products are being working, researched to get an upgraded product.

Impact of COVID-19 on Radiation Therapy Market

The neoplastic patients were at concern with their need for timely diagnosis, treatment, and symptom palliation due to the pandemic lockdown.During the pandemic, there was an increased number of treatments for some cancers and on the other hand, some radiotherapy treatments fell significantly.

The increase in the number of cancer treatments via radiation therapy was due to reduced surgical procedures, which lead the doctors to give radiation therapy as an alternative solution for the surgery.

In response to safety from the COVID-19 virus. professional bodies internationally issued guidance for cancer care. The suggestions were treatment omission or delay, utilizing radiation therapy to replace or to bridge to surgery, and use of short and high-daily-dose (HDR or hypo-fractionated) radiotherapy.

Market Segmentation

Radiation Therapy Market (by Radiation Type)

Under this segmentation, the radiation therapy market in divided into external beam radiation and internal beam radiation.

The external beam radiation segment dominates the market with a share of 82.8% of global radiation therapy market mainly due to the more treatment processes being conducted by external beam radiation therapy systems.

Internal beam radiation segment is expected to register a higher CAGR then external beam radiation segment, the CAGR is 6.7% during the forecast period.

Radiation Therapy Market (by Product Type)

Under this segmentation, the radiation therapy market in divided into oncology systems, particle therapy systems (proton and heavy-ion), and others.

The oncology systems segment which consists traditional radiation therapy systems (x-ray, gamma, cobalt-60 external beam radiation therapy systems, and internal beam radiation therapy systems, among others) dominates the radiation therapy market with a share of 81.9% of global radiation therapy market mainly due to the number of installed bases of traditional systems and internal beam radiation therapy systems, number of procedures being conducted, and the cost of the systems and the procedure when compared with the proton or heavy-ion radiation therapy systems.

Particle therapy systems (proton and heavy-ion) segment is expected to register a higher CAGR of 7.5% during the forecast period.

Radiation Therapy Market (by Therapy)

Under this segmentation, the radiation therapy market in divided into stereotactic radiosurgery (SRS), brachytherapy, image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), and volumetric-modulated arc therapy (VMAT).

The stereotactic radiosurgery (SRS) segment dominates the radiation therapy market with a share of 40% of global market mainly due to the number of procedures being performed by the surgeons and clinicians.

Volumetric-modulated arc therapy segment is expected to register a higher CAGR of 6.8% during the forecast period.

Radiation Therapy Market (by End-User)

Under this segmentation, the radiation therapy market in divided into hospitals and medical research institutes, and specialized radiotherapy centers (SRCs).

The hospitals and medical research institutes segment dominates the radiation therapy market with a share of 84.5% of global market mainly due to the number of hospitals, medical and research institutes providing access to the radiotherapy for the patients.

Specialized radiotherapy centers (SRCs) segment is expected to register a higher CAGR of 6.2% during the forecast period.

Radiation Therapy Market (by Region)

The different regions covered under the radiation therapy in oncology market report includes North America, Europe, Asia-Pacific, and Rest-of-the-World.

North America dominates the radiation therapy market in 2020 and is anticipated to uphold its dominance throughout the forecast period. The growth in the market is majorly driven by the increasing research and development activities and many companies being located in the U.S.

Asia-Pacific market is expected to grow with a higher CAGR of 5.8% during the forecast period.

Key Market Players and Competition Synopsis

Some of the key players operating in the market, include Accuray Inc., Eckert & Ziegler AG, Elekta AB, General Electric Company, Hitachi Ltd., Ion Beam Applications SA, Koninklijke Philips N.V., Mevion Medical Systems Inc., TeamBest Group, Reflexion Medical Inc., Sensus Healthcare Inc., Varian Medical Systems Inc. (Siemens Healthineers AG), Xoft Inc. (iCAD Inc.), Xstrahl Inc., Zap Surgical Systems Inc.

The radiation therapy market market has witnessed several strategic and technological developments in the past four years, undertaken by the different market players to attain their respective market shares in this emerging domain.Some of the strategies covered in this segment are product development and upgradations, partnerships, collaborations, business expansions, funding activities, regulatory approvals, mergers, and acquisitions.

The preferred strategy for companies has been partnerships, collaborations, and business expansions.

Countries Covered
• North America
• U.S.
• Canada
• Europe
• Germany
• Italy
• Spain
• France
• U.K.
• Rest-of-Europe
• Asia-Pacific
• China
• Australia and New Zealand
• Japan
• India
• South Korea
• Rest-of-Asia-Pacific
• Rest-of-the-World

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Disposable Ostomy Bags Market Research Report by Product, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • $ 4949
  • October 2021
  • 186 pages

Disposable Ostomy Bags Market Research Report by Product (One Piece Bag and Two Piece Bag), by Application (Colostomy, Ileostomy, and Urostomy), by Region (Americas, Asia-Pacific, and Europe, Middle East ...

  • World
  • Marketing Research
  • Healthcare
  • Industry analysis

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on